Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The combination of GLP-1 receptor agonists like Wegovy with naltrexone—an opioid antagonist—has gained attention in weight loss medicine because the two drugs work through different metabolic pathways. Naltrexone may enhance appetite suppression and increase energy expenditure when paired with semaglutide, though clinical evidence for this combination remains limited compared to GLP-1 monotherapy.

How Semaglutide and Naltrexone Work Together

Semaglutide activates GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing hunger signals. Naltrexone blocks mu-opioid receptors in the hypothalamus and works to suppress appetite through a different mechanism—one that may complement GLP-1 action by lowering the body's natural opioid tone related to food reward. The theoretical synergy is that naltrexone can amplify satiety and potentially lower the effective dose of semaglutide needed.

Most clinical data on semaglutide-naltrexone combination comes from the IMCOSI trial and smaller observational studies, which showed modest additional weight loss (2–5%) compared to GLP-1 alone in some patients. However, the magnitude of benefit varies widely among individuals, and the combination is not yet standard of care. PlexusDx Precision Peptide Genetic Test can identify whether your MC4R and GLP1R pathways suggest responsiveness to single-agent versus dual-compound strategies.

Safety Profile: Combining These Weight Loss Medications

When semaglutide and naltrexone are used together, the side effect profile reflects both agents: nausea, vomiting, and gastrointestinal upset from semaglutide, plus potential dizziness or liver enzyme changes from naltrexone at higher doses (50 mg). Naltrexone requires baseline liver function testing and is contraindicated in patients with acute hepatitis or liver failure, or those taking opioid medications. The combination has not been associated with serious drug interactions in published studies, but requires careful baseline assessment.

Neither medication should be initiated without medical supervision, and dosing must be staggered—typically starting with low-dose naltrexone (4.5 mg) while ramping semaglutide on its standard titration schedule. Patients on concurrent opioid therapy cannot use naltrexone. PlexusDx's licensed 503A compounding pharmacies prepare semaglutide alone or in dual-compound formulations (GLP-Squared), with telehealth clinicians who screen for contraindications before dispensing.

Clinical Evidence for Semaglutide-Naltrexone Combination

The strongest evidence for semaglutide plus naltrexone comes from the IMCOSI phase 2b trial (2021), which enrolled 338 patients and found that the combination resulted in approximately 20% body weight loss over 48 weeks, compared to 16% for semaglutide alone—a difference that was statistically significant but modest in absolute terms. The trial used fixed naltrexone doses (4.5 mg daily) paired with semaglutide up to 2.4 mg weekly. Discontinuation rates due to adverse events were higher in the combination arm (16% vs. 11%), driven mainly by gastrointestinal complaints.

Real-world registry data and physician reports suggest some patients experience greater appetite suppression or sustained weight loss maintenance when naltrexone is added after reaching a semaglutide plateau. However, published randomized trials remain limited, and most weight loss practices consider the combination experimental rather than first-line. PlexusDx focuses on optimizing single-agent GLP-1 therapy through genetic insights and compounding precision before recommending add-on strategies.

PlexusDx Personalized Approach vs. Combination Therapy

Rather than assuming all patients need dual therapy, PlexusDx uses the Precision Peptide Genetic Test to map your GLP1R, GIPR, FTO, and MC4R pathways—revealing whether you may respond robustly to semaglutide monotherapy or could benefit from our GLP-Squared dual-compound option (semaglutide plus tirzepatide in one injection). Compounded Semaglutide Injection starts at $149/month, with pricing flat across dose escalations—meaning your dose may need to go up, but your price won't. This eliminates the financial burden of chasing combination protocols when optimized monotherapy may suffice.

Patients interested in exploring naltrexone-semaglutide combination can discuss this with their PlexusDx clinician during telehealth consultation. However, adding naltrexone requires a separate prescription, additional baseline labs, and ongoing monitoring—complexity that PlexusDx streamlines by offering tailored compounded peptide regimens designed to match your genetic susceptibility profile. GLP-Squared Injection (dual semaglutide-tirzepatide compound) starts at $249/month and may offer synergistic benefits without the need for a separate opioid antagonist.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take Wegovy with naltrexone at the same time?

Semaglutide and naltrexone can be used concurrently and are not contraindicated, but require baseline liver function tests and careful monitoring for GI side effects. Patients on opioid medications cannot use naltrexone. PlexusDx clinicians review safety before recommending any combination approach during your telehealth visit.

Does naltrexone make semaglutide work better?

Clinical trials show modest additional weight loss (2–5%) when naltrexone is added to semaglutide, but the benefit varies significantly between individuals. The IMCOSI trial demonstrated approximately 20% weight loss with the combination versus 16% with semaglutide alone over 48 weeks, though discontinuation rates were higher due to side effects.

What does PlexusDx Precision Peptide Genetic Test tell me about this combination?

The test maps your GLP1R, MC4R, GIPR, and FTO variants across 14 pathways and 150+ genetic insights. This reveals whether you're likely a strong responder to single-agent GLP-1 therapy or could benefit from PlexusDx's GLP-Squared dual-compound option (semaglutide plus tirzepatide) as an alternative to naltrexone addition. The test is $99 as an add-on after your first month of treatment.

How much does PlexusDx semaglutide cost if I want to add naltrexone?

Compounded Semaglutide Injection from PlexusDx starts at $149/month with flat pricing across all dose levels—your dose may go up, but your price won't. Naltrexone would be a separate prescription obtained through your clinician and local pharmacy, with typical costs ranging $30–$80/month. HSA and FSA funds are eligible for PlexusDx medications.

What side effects should I expect if I combine semaglutide and naltrexone?

The combination carries GI side effects from semaglutide (nausea, vomiting, diarrhea) plus potential naltrexone-related symptoms (dizziness, headache, insomnia) and requires liver monitoring because naltrexone can elevate enzymes. The IMCOSI trial found 16% discontinuation due to adverse events in the combination arm, higher than semaglutide alone.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves